Such synthetic circuitry would thus be able to sense the magnitude of some analogue input, make a determination about the proper reaction to that level, and then have an appropriate output to the situation.
For example, circuits that might be designed in the future may be used to monitor levels of glucose in the blood, and then respond in a variety of ways depending on what the concentration was. “If the glucose level was too high you might want your cells to produce insulin, if the glucose was too low you might want them to make glucagon, and if it was in the middle you wouldn’t want them to do anything,” says Timothy Lu, Associate Professor in the Department of Electrical Engineering and Computer Science at MIT and leader of the research team that did this work.
“Most of the work in synthetic biology has focused on the digital approach, because [digital systems] are much easier to program,” Lu says.
Digital computing systems are based on binary output like 0 or 1, so executing complex operations requires a large number of parts to carry them out, a feature that is very challenging for artificial biological systems.
“Digital is basically a way of computing in which you get intelligence out of very simple parts, because each part only does a very simple thing, but when you put them all together you get something that is very smart,” Lu explains. “But that requires you to be able to put many of these parts together, and the challenge in biology, at least currently, is that you can’t assemble billions of transistors like you can on a piece of silicon,” he continues.
“So this is how we take an analogue input, such as a concentration of a chemical, and convert it into a 0 or 1 signal,” Lu says. “And once that is done, and you have a piece of DNA that can be flipped upside down, then you can put together any of those pieces of DNA to perform digital computing,” he explains.
For starters, the research team is testing the concept of using analogue-to-digital converters to monitor inflammation in the gut caused by dysfunction such as inflammatory bowel disease, and releasing varying amounts of a drug treatment in response.
Another idea is to engineer immune cells used for cancer treatment to detect different environmental conditions, like tumor lysis or oxygen levels, and alter their therapeutic action in response.
Learn more about engineering and programming gene circuits in the video below.
Sources: MIT, Nature Communications